Quantitative proteomics identification of phosphoglycerate mutase 1 as a novel therapeutic target in hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide with poor prognosis due to resistance to conventional chemotherapy and limited efficacy of radiotherapy. There is an urgent need to develop novel biomarkers for early diagnosis, as well as to identify new dru...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Fenglian, Wu, Hong, Lei, Yunlong, Zhang, Haiyuan, Liu, Rui, Zhao, Yong, Chen, Xiancheng, Zeng, Dequan, Tong, Aiping, Chen, Lijuan, Wei, Yuquan, Huang, Canhua
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873438/
https://www.ncbi.nlm.nih.gov/pubmed/20403181
http://dx.doi.org/10.1186/1476-4598-9-81

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873438/
https://www.ncbi.nlm.nih.gov/pubmed/20403181
http://dx.doi.org/10.1186/1476-4598-9-81

Ejemplares similares